]-des-Arg 9 -BK ϭ BK. The BK peptides also produced an immediate, transient increase followed by a sustained increase in arterial blood pressure and an initial decrease followed by an increase in heart rate. Strong tachyphylaxis occurred for the cardiovascular effect but not for the antidipsogenic effect. The order of the potency of the cardiovascular actions, [Arg 0 ]BK Ͼ BK Ͼ [Arg 0 ]-des-Arg 9 -BK, was different from that of the antidipsogenic action. Slow infusions of eel [Arg 0 ]BK in the dose range 1-1,000 pmol ⅐ kg Ϫ1 ⅐ min Ϫ1 produced concentration-dependent inhibition of drinking without changes in arterial pressure, plasma osmolality, and hematocrit. At the infusion rate of Ͼ100 pmol ⅐ kg Ϫ1 ⅐ min Ϫ1 , plasma concentrations of angiotensin II, a potent dipsogenic hormone in eels, increased, suggesting an interaction of the kallikrein-kinin and reninangiotensin systems. In mammals, BK is dipsogenic and vasodepressor, so that our data demonstrate opposite effects on fluid and cardiovascular regulation of BK in the eel and suggest a new physiological role for the kallikrein-kinin system in teleost fish. kallikrein-kinin system; renin-angiotensin system; drinking behavior; cardiovascular effects; teleost fish BRADYKININ (BK) is an active component of the kallikrein-kinin system that exhibits profound actions on smooth muscle contraction and vascular permeability in mammals (22). In nontetrapod species, several molecular forms of BK have been isolated from the plasma of actinopterygian (sturgeon, gar, bowfin, cod, and trout) as well as sarcopterygian (lungfish) bony fish, but their functions have not been fully elucidated (reviewed in Ref.
]BK, was identical to two previously identified BK homologs from cod and trout. High conservation of the BK sequence among distant teleost species suggests an important function in this vertebrate group. Bolus intra-arterial injections of eel ]-des-Arg 9 -BK ϭ BK. The BK peptides also produced an immediate, transient increase followed by a sustained increase in arterial blood pressure and an initial decrease followed by an increase in heart rate. Strong tachyphylaxis occurred for the cardiovascular effect but not for the antidipsogenic effect. The order of the potency of the cardiovascular actions, [Arg 0 ]BK Ͼ BK Ͼ [Arg 0 ]-des-Arg 9 -BK, was different from that of the antidipsogenic action. Slow infusions of eel [Arg 0 ]BK in the dose range 1-1,000 pmol ⅐ kg Ϫ1 ⅐ min Ϫ1 produced concentration-dependent inhibition of drinking without changes in arterial pressure, plasma osmolality, and hematocrit. At the infusion rate of Ͼ100 pmol ⅐ kg Ϫ1 ⅐ min Ϫ1 , plasma concentrations of angiotensin II, a potent dipsogenic hormone in eels, increased, suggesting an interaction of the kallikrein-kinin and reninangiotensin systems. In mammals, BK is dipsogenic and vasodepressor, so that our data demonstrate opposite effects on fluid and cardiovascular regulation of BK in the eel and suggest a new physiological role for the kallikrein-kinin system in teleost fish.
kallikrein-kinin system; renin-angiotensin system; drinking behavior; cardiovascular effects; teleost fish BRADYKININ (BK) is an active component of the kallikrein-kinin system that exhibits profound actions on smooth muscle contraction and vascular permeability in mammals (22) . In nontetrapod species, several molecular forms of BK have been isolated from the plasma of actinopterygian (sturgeon, gar, bowfin, cod, and trout) as well as sarcopterygian (lungfish) bony fish, but their functions have not been fully elucidated (reviewed in Ref. 3) . The kallikrein-kinin system has attracted the attention of basic and clinical researchers in relation to the renin-angiotensin system, because both systems utilize a common enzyme, ANG I-converting enzyme (ACE) or kininase II, which is responsible for production of ANG II and degradation of BK (9) .
Various types of ACE inhibitors have been used to prevent activation of the renin-angiotensin system. However, their application often produces unexpected results that cannot be explained solely by the inhibition of ANG II formation. In a previous study, we found that captopril infused at low doses resulted in marked depression of drinking and arterial pressure in seawater-adapted eels (30) . Because immunoneutralization of plasma ANG II with a specific antiserum did not affect drinking and arterial pressure in the eels, the effects of captopril may not be due to the inhibition of ANG II formation in plasma. In mammals, BK is known to be dipsogenic and vasodepressor when given systemically in combination with captopril (8) . If this is also the case in the eel, the vasodepressor effect of captopril observed in the previous study may be mediated by an increase in plasma BK concentrations. However, the cardiovascular effects of BK in teleost fishes are species dependent (19, 20) , and there appears to be no report on the effects of BK on drinking in fish.
The present study was undertaken to examine the effect of BK on drinking and arterial blood pressure in eels. To use homologous BK in the study, we first isolated BK from heat-denatured eel plasma after incubation with porcine pancreatic kallikrein. The amino acid sequence of European eels, Anguilla anguilla, has been determined except for a single residue (7) . To assess the type of BK receptors mediating each activity, the effects of selected eel BK analogs (BK for B 2 receptor and [Arg 0 ]-des-Arg 9 -BK for B 1 receptor) were also examined. Because bolus injections of eel BK markedly increased arterial pressure, which in itself may affect drinking in eels (12) , eel BK was infused slowly at nonpressor doses to mimic more closely the physiological changes expected from activation of the endogenous kallikrein-kinin system. Concentrations of ANG II in plasma were monitored during BK infusion, because ANG II is a potent dipsogen in eels (33) .
MATERIALS AND METHODS

Animals
Cultured eels, Anguilla japonica (ϳ200 g body wt), were purchased from a local dealer. They were kept in a 1-ton freshwater tank for 1 wk to acclimate to laboratory conditions. To prepare seawater-adapted eels, specimens were transferred to a 0.5-ton seawater tank Ͼ2 wk before use. Water in the tank was continuously filtered, aerated, and maintained at 18 Ϯ 0.5°C. Eels were not fed after purchase and were used within 2 wk after acclimation to seawater.
Eel BK Sequence
Production of eel BK. Freshwater eels were anesthetized by immersion for 5 min in 0.2% (wt/vol) tricaine methanesulfonate (Sigma, St. Louis, MO) neutralized with sodium bicarbonate. Blood was collected from the caudal vein into a chilled syringe containing 3.8% sodium acetate (10 l/ml blood). The blood was centrifuged, and plasma was immediately frozen on dry ice. A total of 75 ml of plasma was collected from 30 eels weighing 203.3 Ϯ 2.4 (SE) g. Plasma was thawed and heated to Ͼ90°C in 450 ml of 0.2% acetic acid for 30 min to inhibit proteolytic enzyme activity. After the plasma was cooled, 50 ml of 0.5 M Tris ⅐ HCl (pH 7.8) containing 1 M NaCl were added to the mixture, and the pH was adjusted to 7.8 with 10 M NaOH. The mixture was incubated with porcine pancreatic kallikrein (1,000 U, Sigma) at 37°C for 90 min with gentle agitation. The reaction was terminated by addition of 1 ml of trifluoroacetic acid (TFA), and the mixture was centrifuged at 40,000 g for 30 min at 4°C to remove the precipitate. The supernatant was passed through activated Sep-Pak C 18 cartridges (Waters, Milford, MA), and the adsorbed materials were eluted with 70% acetonitrile-water containing 0.1% (vol/vol) TFA. The eluant was lyophilized and transported to Creighton University for peptide purification studies.
Purification of eel BK. The kallikrein-treated plasma extract, after partial purification on Sep-Pak cartridges, was redissolved in 3 ml of 1% TFA and chromatographed on a 90 ϫ 1.6-cm column of Sephadex G-25 (Pharmacia, Uppsala, Sweden) equilibrated with 1 M acetic acid. The column was eluted at a flow rate of 24 ml/h, and fractions (2 ml) were collected. Absorbance was measured at 280 nm. The concentration of immunoreactive BK in the fractions was determined by radioimmunoassay (15) . Fractions containing immunoreactive BK were pooled and injected onto a 25 ϫ 1-cm Vydac 218TP510 (C18) column (Separations Group, Hesperia, CA) equilibrated with 0.1% TFA at a flow rate of 2 ml/min. The concentration of acetonitrile in the eluting solvent was raised to 14% over 10 min and to 35% over 50 min using linear gradients. Absorbance was monitored at 214 and 280 nm, and fractions (2 ml) were collected. The fraction containing immunoreactive BK (Fig. 1A ) was sequentially rechromatographed on 25 ϫ 0.46-cm columns of Vydac 214TP54 (C4), Vydac 219TP54 (phenyl), and Supelcosil LC-18-DB (C18; Supelco Bellefonte, PA) at a flow rate of 1.5 ml/min.
Structural analysis. The primary structure of the peptide was determined by automated Edman degradation using a sequenator (model 471A, Applied Biosystems). Electrospray mass spectrometry was carried out using a single-quadrupole -BK) were synthesized as previously described (13), and their identities was confirmed by amino acid sequencing and mass spectrometry. All peptides were Ͼ95% pure.
Physiological Studies
Surgical procedures. A total of 20 seawater-adapted eels were used: 8 for experiment 1 (178.8 Ϯ 4.8 g), 6 for experiment 2 (184.3 Ϯ 8.2 g), and 6 for experiment 3 (183.9 Ϯ 3.1 g). Eels were anesthetized in 0.1% tricaine methanesulfonate for 10 min. In eels used for experiments 1 and 2, vinyl tubes (1.5 mm OD) were inserted into the esophagus and stomach for measurement of drinking rates as described previously (31) . In all eels, a polyethylene cannula (0.8 mm OD) was inserted into the dorsal aorta for administration of BK and measurement of blood pressure. In eels used for experiments 2 and 3, another similar cannula was inserted into the ventral aorta for blood sampling. Eels that bled Ͼ0.5 ml (7% of total blood volume) were excluded from the study, since these fish usually drink at a higher rate because of hypovolemia and increased plasma ANG II (28) . After surgery, the esophageal catheter was connected to a drop counter for continuous measurement of drinking rate, and the stomach catheter was connected to a pulse injector synchronized with the drop counter for reintroduction of the water that had been drunk (31) . Eighty percent seawater was reintroduced into the stomach, since ingested seawater that appeared from the esophageal catheter was diluted to this concentration because of a facilitated absorption of Na ϩ and Cl Ϫ by the esophagus of seawater eels (32) . The cannula in the dorsal aorta was connected via a three-way stopcock to a pressure transducer (model DX-300, Nihon Kohden, Tokyo, Japan) for continuous measurement of arterial pressure and to a syringe for injection or infusion in experiments 1 and 2. Eels were allowed to recover for Ͼ18 h postoperatively.
Experimental protocol. In experiment 1, eels received bolus injections of eel [Arg 0 ]BK, BK, and [Arg 0 ]-des-Arg 9 -BK at doses of 1, 3, and 10 nmol/kg in 0.05 ml of vehicle (0.9% NaCl containing 0.01% Triton X-100) over 10 s. Injections of vehicle alone served as controls. Because strong tachyphylaxis occurred for the cardiovascular effects that lasted for several hours after injection of high doses of BK, injections were made from low to high doses at sufficient intervals (Ն1 h). Bolus injections caused acute increases in arterial blood pressure, which probably affected drinking rates (12) . In experiments 2 and 3, therefore, [Arg 0 ]BK, which was shown to be the most potent peptide in experiment 1, was infused slowly at a rate of 0.6 ml/h (experiment 2) or 0.4 ml/h (experiment 3) to minimize changes in pressure. Infusions were started with vehicle only for 30 min, then increasing doses of [Arg 0 ]BK (1, 10, 100, and 1,000 pmol ⅐ kg Ϫ1 ⅐ min Ϫ1 ) and, finally, vehicle were infused for 2 h. To nullify the increase in blood volume caused by the infusion, blood (0.3 or 0.2 ml) was withdrawn every 30 min into a chilled syringe containing 10% (wt/vol) K2EDTA (10 l/ml blood). In experiment 2, ANG II concentrations in plasma were measured by radioimmunoassay as described previously (30 ]ANG II (eel ANG II) but negligible cross-reactivity with eel angiotensin I (35) . The intra-and interassay coefficients of variation were 5.2% and 12.6%, respectively. In experiment 3, an aliquot of blood was transferred to a capillary tube for determination of hematocrit. The remaining blood was centrifuged, and plasma was used for determination of plasma Na ϩ concentration by an atomic absorption spectrophotometer (model Z5300, Hitachi, Tokyo, Japan) and plasma osmolality by a vapor pressure osmometer (VAPRO 5520, Wescor, Logan, UT). All determinations were made in duplicate or triplicate.
Analysis of data. The time-course data were analyzed statistically by ANOVA followed by Bonferroni/Dunn's test at each time point. The dose-response relationship was examined by ANOVA followed by a regression analysis. The difference of responses between doses was examined by randomization test for matched pairs (25) -BK) for the antidipsogenic and cardiovascular effect was examined by two-way ANOVA with repeated measures. Significance was determined at P Ͻ 0.05. Values are means Ϯ SE.
RESULTS
Eel BK Sequence
Purification of eel BK. The BK-like immunoreactivity in the kallikrein-treated eel plasma was eluted from a Sephadex G-25 column as a single broad peak with maximum immunoreactivity at the elution volume of mammalian BK. The immunoreactive fractions were pooled and injected onto a semipreparative Vydac C 18 column (Fig. 1A) . Immunoreactive BK was eluted in a single fraction (horizontal bar in Fig. 1A) . After rechromatography of this material on a Vydac C 4 column (Fig. 1B) , the immunoreactive BK was associated with the major peak (arrows). Further chromatography on a Vydac phenyl column (Fig. 1C) revealed that the material was extremely heterogeneous, and the immunoreactive BK was associated with the minor peak (arrows). Eel BK was purified to near homogeneity by a final chromatography on a Supelcosil C 18 column (Fig.  1D) . The final yield of purified peptide was ϳ1 nmol.
Structural characterization. The primary structure of purified peptide was established as Arg (41) (19) , where the values in parentheses are the yields of amino acid phenylthiohydantoins in picomoles. The proposed structure was confirmed by mass spectrometry, inasmuch as the observed molecular mass (1,220.9) was almost identical to the calculated monoisotopic molecular mass (1,220.7).
Physiological Studies
The mean values for drinking rate, dorsal aortic pressure, and heart rate of unanesthetized seawateradapted eels were 5.0 Ϯ 1.1 ml/h (n ϭ 14), 18.1 Ϯ 1.2 mmHg (n ϭ 14), and 85.0 Ϯ 3.9 beats/min (n ϭ 8), respectively, before start of injections or infusions. Heart rate was not measured in experiment 2. Drinking rate was highly variable, even though the eels that bled Ͼ0.5 ml were excluded from the data. Experiment 1. Bolus injections of the eel BK-related peptides potently inhibited drinking in seawater eels (Fig. 2) . The magnitude of the antidipsogenic effect was dose dependent, and significant differences were detected among different doses of [Arg 0 ]BK. The duration of the antidipsogenic effect was longer at higher doses; the inhibition lasted for ϳ30 min after 10 nmol/kg of [Arg 0 ]BK (Fig. 3) . The BK peptides also induced an immediate increase in arterial pressure that was followed by a small but long-lasting increase (Fig. 2) . In two of eight eels, the decrease in pressure between the two increases was below the basal level and so represented a triphasic increase-decrease-increase pattern, as reported in the trout after [Arg 0 ]BK injection (20) . The heart rate decreased immediately after injection and then slowly increased above the initial level (Fig.  2) . Vehicle injection did not significantly alter drinking rate and cardiovascular parameters. Among the three BK peptides examined, [Arg 0 ]BK was most potent followed by BK and [Arg 0 ]-des-Arg 9 -BK, both of which had a similar potency for the antidipsogenic effect (Fig.  4) . The dose dependency of the antidipsogenic effect was statistically significant (P Ͻ 0.05) only with infusion, despite a synergic action of vasoactive ANG II, the circulating concentration of which increased at high doses (Fig. 6 ). [Arg 0 ]BK infusion did not alter plasma Na ϩ concentration and osmolality at any doses examined. Hematocrit decreased gradually during the course of infusions, and the decrease became significant (P Ͻ 0.05) during the last saline infusion. However, [Arg 0 ]BK did not change hematocrit at any doses.
DISCUSSION
In the present study, a BK-related peptide (eel [Arg 0 ]BK) was isolated from kallikrein-treated plasma of the Japanese eel A. japonica, and its amino acid sequence was determined. Using a synthetic replicate of the eel [Arg 0 ]BK, novel and potent antidipsogenic effects were demonstrated in seawater-adapted eels that drink continuously at high rates. Bolus injections of eel [Arg 0 ]BK also exhibited biphasic vasopressor and cardiac effects that were similar to those demonstrated in other teleost species (19, 20) . Slow infusions of eel [Arg 0 ]BK inhibited drinking without changes in arterial pressure, confirming its potent antidipsogenic effect.
Biochemical Studies
In a series of studies (reviewed in Ref. 3) , it has been demonstrated that BK-related peptides, with different amino acid sequences, are generated in the plasma of various nonmammalian species by incubation of heatdenatured plasma with glass beads or with BK-producing enzymes (kallikreins). In teleost fish, attempts to activate the Hageman factor by incubation with glass beads, which in mammals and reptiles results in activation of intrinsic plasma prekallikrein (1), were without effect. However, incubation of fish plasma with mammalian tissue kallikrein produced a BK-related peptide in the cod and trout that differs from mammalian BK by the presence of an additional NH 2 -terminal arginine residue (Arg 0 ) and by the substitutions (Phe appears to be an active form of the kallikrein-kinin system in teleost fishes (19, 20) .
As well as being the most potent with respect to cardiovascular and antidipsogenic effects in the eel, [Arg 0 ]BK is appreciably more potent than BK in its vasopressor action in the cod in vivo (20) and in its contractile action on trout gastric smooth muscle in vitro (13) . This suggests that the endogenous active peptide circulating in the blood in teleost fish may be [Arg 0 ]BK rather than BK. Unfortunately, the antiserum to mammalian BK used in this study was not sufficiently sensitive to detect circulating levels of BK in the eel arising from activation of the animal's kallikrein-kinin system. To determine the circulating form of BK and the changes in the plasma concentration after physiological stimuli in fish, it is necessary to develop a sensitive and specific radioimmunoassay for [Arg 0 ,Trp 5 ,Leu 8 ]BK for teleost fishes. In general, the primary structures of the BK-related peptides have been poorly conserved during evolution, and the variation in amino acids occurs at positions 1, 2, 5, 6, 7, and 8. It is somewhat surprising, therefore, that teleost species (eel, trout, and cod) that are only distantly related and arose from ancient divergences (18) have an identical BK sequence. In other oligopeptide hormones similar in size to BK such as ANG I, 7 of 10 amino acid residues are conserved across different vertebrate groups, but trout and eel have different sequences (27) . Consequently, the fact that the sequence of BK has been strongly conserved in teleost fish may indicate its essential physiological functions in this vertebrate group.
Physiological Studies
In seawater eels, slow infusion of captopril profoundly inhibited drinking and decreased arterial pressure with only a small decrease in plasma ANG II concentration (30) . Because captopril inhibits not only ANG II formation but also degradation of plasma BK, plasma BK should have increased during captopril infusion. The present study showed that BK is one of the candidates for the antidipsogenic effect of captopril. However, BK may not be responsible for the vasodepressor effect of captopril, since chronic elevation of plasma BK by infusions did not alter arterial pressure in this study.
In mammals such as the rat (11), BK is recognized as a vasoactive hormone that causes an immediate hypotension when injected systemically through a decrease in peripheral resistance (6, 21, 23) . BK also exhibits a weak dipsogenic effect when injected systemically with captopril (8) . Therefore, the vasopressor and antidipsogenic effects of native BK peptides in the eel are largely opposite to the effects observed in mammals. In other nonmammalian species, the effects of BK on drinking have not been examined, but homologous BK has diverse cardiovascular actions in birds (14) and reptiles (2, 4, 34) . In vitro, BK is vasorelaxant in isolated arteries of mammals, but it is only weakly vasoactive in the isolated vessels and the perfused trunk of the trout (5) .
In the present study, bolus injections and slow infusions of [Arg 0 ]BK, the latter mimicking more closely the physiological changes that may occur in vivo, inhibited drinking in seawater eels. The inhibition occurred even though plasma ANG II concentration increased to the level strongly dipsogenic in the eel (33) . Therefore, it is obvious that [Arg 0 ]BK is a strong antidipsogenic hormone in the eel. The increase in plasma ANG II concentration caused by BK did not increase arterial pressure in the present study, although the similar increase of ANG II alone caused by infusion was vasopressor (33) . It seems that interactions of multiple hormonal systems, including the renin-angiotensin and kallikrein-kinin systems, should have occurred for physiological regulation of body fluid and pressure homeostasis in the eel.
Our previous study showed that infusion of atrial natriuretic peptide (ANP) decreases plasma Na ϩ concentration with concomitant inhibition of drinking in seawater eels (29) . In the present study, BK did not alter plasma Na ϩ concentration and osmolality, even though drinking was inhibited to the level similar to that of ANP inhibition. Thus it seems that the decrease in plasma Na ϩ concentration after ANP is due to its potent inhibitory action on intestinal NaCl absorption (16) , while BK may not act on the intestine to inhibit NaCl absorption in the eel. Because hematocrit also did not change during BK infusions, BK may not have altered blood volume, although hematocrit is not an ideal marker for changes in blood volume in the eel (26) .
Perspectives
BK receptors in mammals have been classified into B 1 and B 2 subtypes on the basis of different affinities toward selected BK agonists and antagonists (10) . The B 1 receptor has a high affinity for des-Arg 9 -BK and [Arg 0 ]-des-Arg 9 -BK, while BK selectively activates the B 2 receptor. In nonmammalian vertebrates, a BK receptor has been cloned in only one species, the chicken (24) . In teleost fish, BK receptors have been characterized pharmacologically to some extent using different BK peptides (20) . In the eel, [Arg 0 ]-des-Arg 9 -BK was as potent as BK for the antidipsogenic effect, while it was much less effective for the cardiovascular effects. Furthermore, strong tachyphylaxis occurred with the cardiovascular effects but not with the antidipsogenic effect. These results warrant further studies to determine whether the antidipsogenic and cardiovascular actions in the eel are mediated through activation of different receptors.
The site of antidipsogenic action of eel [Arg 0 ]BK was not addressed in this study, but it is possible that the peptide acts on the brain to modulate drinking rate as observed for the dipsogenic effect of ANG II in the same species (28) . A precise regulation of the rate of drinking is essential to the survival of marine teleosts that exist in a hyperosmotic environment. Our observation that infusion of high doses of [Arg 0 ]BK causes the release of ANG II suggests that the kallikrein-kinin and reninangiotensin systems may operate in opposition to regulate the rate of drinking in the teleost fish. An integrative approach to the interaction of multiple hormonal systems for regulation of drinking may assume increasing importance in the future.
